P765: UPDATED ENROLLMENT AND RESULTS FROM THE PHASE 1 SUBSTUDY OF IVOSIDENIB IN PATIENTS WITH IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME (R/R MDS)

• C. D. DiNardo,
• J. M. Foran,
• J. M. Watts,
• E. M. Stein,
• S. de Botton,
• A. T. Fathi,
• G. T. Prince,
• R. M. Stone,
• P. A. Patel,
• G. J. Roboz,
• M. L. Arellano,
• H. P. Erba,
• A. Pigneux,
• P. Baratam,
• R. K. Stuart,
• X. Thomas,
• I. R. Lemieux,
• X. Bai,
• S. M. Kapsalis,
• G. Garcia-Manero,
• D. A. Sallman

Affiliations

C. D. DiNardo

1 MD Anderson Cancer Center, University of Texas, Houston

J. M. Foran

2 Mayo Clinic, Jacksonville

J. M. Watts

3 Sylvester Comprehensive Cancer Center, University of Miami, Miami

E. M. Stein

4 Memorial Sloan Kettering Cancer Center, New York, United States of America

S. de Botton

5 Institut Gustave Roussy, Villejuif, France

A. T. Fathi

6 Massachusetts General Hospital, Harvard Medical School, Boston

G. T. Prince

7 Johns Hopkins Hospital, Baltimore

R. M. Stone

8 Dana-Farber Cancer Institute, Boston

P. A. Patel

9 University of Texas Southwestern Medical Center, Dallas

G. J. Roboz

10 Weill Cornell Medicine and The New York Presbyterian Hospital, New York

M. L. Arellano

11 Winship Cancer Institute, Emory University School of Medicine, Atlanta

H. P. Erba

12 Duke University, Durham, United States of America

A. Pigneux

13 Centre Hospitalier Universitaire de Bordeaux Haut-Lévêque, Pessac, France

P. Baratam

14 Medical University of South Carolina, Charleston, United States of America

R. K. Stuart

14 Medical University of South Carolina, Charleston, United States of America

X. Thomas

15 Centre Hospitalier Universitaire de Lyon-Sud, Lyon, France

I. R. Lemieux

16 Servier Pharmaceuticals LLC, Boston

X. Bai

16 Servier Pharmaceuticals LLC, Boston

S. M. Kapsalis

16 Servier Pharmaceuticals LLC, Boston

G. Garcia-Manero

1 MD Anderson Cancer Center, University of Texas, Houston

D. A. Sallman

17 Moffitt Cancer Center, Tampa, United States of America